Natural and Induced T CD4+CD25+FOXP3+ Regulatory T Cells

Methods in Molecular Biology

Volumn 677, Issue , 2011, Pages 3-13

  Chatenoud, Lucienne ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Foxp3; Immune regulation; Induced regulatory T cells; Natural regulatory T cells

Indexed keywords

ANTIGEN; AUTOANTIGEN; CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; HLA ANTIGEN CLASS 2; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLASSIFICATION; HUMAN; IMMUNOLOGY; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; THYMUS;

ANTIGENS; ANTIGENS, CD4; AUTOANTIGENS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 79952201053     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-869-0_1     Document Type: Chapter

References (48)

1. Gershon, R.K., and K. Kondo. 1971. Infectious immunological tolerance. Immunology 21:903–914.
2. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151–1164.
3. Kim, J.M., and A. Rudensky. 2006. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev 212:86–98.
4. Fontenot, J.D., J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22:329–341.
5. Chen, W., W. Jin, N. Hardegen, K.J. Lei, L. Li, N. Marinos, G. McGrady, and S.M. Wahl. 2003. Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875–1886.
6. Liang, S., P. Alard, Y. Zhao, S. Parnell, S.L. Clark, and M.M. Kosiewicz. 2005. Conversion of CD4+ CD25-cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 201:127–137.
7. Curotto de Lafaille, M.A., A.C. Lino, N. Kutchukhidze, and J.J. Lafaille. 2004. CD25-T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J Immunol 173:7259–7268.
8. Karim, M., C.I. Kingsley, A.R. Bushell, B. S. Sawitzki, and K.J. Wood. 2004. Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process. J Immunol 172:923–928.
9. Cobbold, S.P., R. Castejon, E. Adams, D. Zelenika, L. Graca, S. Humm, and H. Waldmann. 2004. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol 172: 6003–6010.
10. Takahashi, T., T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, N. Sakaguchi, T.W. Mak, and S. Sakaguchi. 2000. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192:303–310.
11. Shimizu, J., S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi. 2002. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3:135–142.
12. Read, S., V. Malmstrom, and F. Powrie. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192: 295–302.
13. Tang, Q., and J.A. Bluestone. 2006. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 212:217–237.
14. You, S., B. Leforban, C. Garcia, J.F. Bach, J.A. Bluestone, and L. Chatenoud. 2007. Adaptive TGF-{beta}-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc Natl Acad Sci USA 104:6335–6340.
15. Mchugh, R.S., M.J. Whitters, C.A. Piccirillo, D.A. Young, E.M. Shevach, M. Collins, and M.C. Byrne. 2002. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16:311–323.
16. Piccirillo, C.A., J.J. Letterio, A.M. Thornton, R.S. Mchugh, M. Mamura, H. Mizuhara, and E.M. Shevach. 2002. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 196:237–246.
17. You, S., M. Belghith, P. Cobbold, M.A. Alyanakian, C. Gouarin, S. Barriot, C. Garcia, H. Waldmann, L. Chatenoud, and J.F. Bach. 2005. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T cells. Diabetes 54(5):1415–1422.
18. Shevach, E.M., R.A. DiPaolo, J. Andersson, D.M. Zhao, G.L. Stephens, and A.M. Thornton. 2006. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev 212:60–73.
19. Billiard, F., E. Litvinova, D. Saadoun, F. Djelti, D. Klatzmann, J.L. Cohen, G. Marodon, and B.L. Salomon. 2006. Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation. J Immunol 177:2167–2174.
20. Nishizuka, Y., and T. Sakakura. 1969. Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166:753–755.
21. Sakaguchi, S., K. Fukuma, K. Kuribayashi, and T. Masuda. 1985. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med 161:72–87.
22. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184:387–396.
23. Suri-payer, E., A.Z. Amar, A.M. Thornton, and E.M. Shevach. 1998. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160:1212–1218.
24. Powrie, F., R. Correa-oliveira, S. Mauze, and R.L. Coffman. 1994. Regulatory interactions between CD45R Bhigh and CD45 RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179: 589–600.
25. Stephens, L.A., C. Mottet, D. Mason, and F. Powrie. 2001. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 31:1247–1254.
26. Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330–336.
27. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057–1061.
28. Khattri, R., T. Cox, S.A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4:337–342.
29. Wildin, R.S., S. Smyk-Pearson, and A.H. Filipovich. 2002. Clinical and molecular features of the immunodysregulation, polyen-docrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 39:537–545.
30. Salomon, B., D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J.A. Bluestone. 2000. B7/CD28 Costimu lation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431–440.
31. Seddon, B., and D. Mason. 1999. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med 189: 877–882.
32. Jordan, M.S., A. Boesteanu, A.J. Reed, A.L. Petrone, A.E. Holenbeck, M.A. Lerman, A. Naji, and A.J. Caton. 2001. Thymic selection of CD4(+)CD25(+) regulatory T cells induced by an agonist self-peptide. Nat Immunol 2:301–306.
33. Knoechel, B., J. Lohr, E. Kahn, J.A. Bluestone, and A.K. Abbas. 2005. Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J Exp Med 202: 1375–1386.
34. Apostolou, I., and H. von Boehmer. 2004. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199:1401–1408.
35. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M.C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6:1219–1227.
36. Mucida, D., N. Kutchukhidze, A. Erazo, M. Russo, J.J. Lafaille, and M.A. Curotto de Lafaille. 2005. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 115:1923–1933.
37. You, S., N. Thieblemont, M.A. Alyanakian, J.F. Bach, and L. Chatenoud. 2006. Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes. Immunol Rev 212:185–202.
38. Curotto de Lafaille, M.A., N. Kutchukhidze, S. Shen, Y. Ding, H. Yee, and J.J. Lafaille. 2008. Adaptive Foxp3+ regulatory T cell-dependent and-independent control of allergic inflammation. Immunity 29:114–126.
39. Liu, V.C., L.Y. Wong, T. Jang, A.H. Shah, I. Park, X. Yang, Q. Zhang, S. Lonning, B.A. Teicher, and C. Lee. 2007. Tumor evasion of the immune system by converting CD4+ CD25-T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol 178:2883–2892.
40. Sun, C.M., J.A. Hall, R.B. Blank, N. Bouladoux, M. Oukka, J.R. Mora, and Y. Belkaid. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204:1775–1785.
41. Barnes, M.J., and F. Powrie. 2009. Regulatory T cells reinforce intestinal homeostasis. Immunity 31:401–411.
42. Josefowicz, S.Z., and A. Rudensky. 2009. Control of regulatory T cell lineage commitment and maintenance. Immunity 30:616–625.
43. Ochi, H., M. Abraham, H. Ishikawa, D. Frenkel, K. Yang, A.S. Basso, H. Wu, M.L. Chen, R. Gandhi, A. Miller, R. Maron, and H.L. Weiner. 2006. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4(+)CD25(-)LAP(+) T cells. Nat Med 12:627–635.
44. Chen, M.L., B.S. Yan, Y. Bando, V.K. Kuchroo, and H.L. Weiner. 2008. Latency-associated peptide identifies a novel CD4+ CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis. J Immunol 180:7327–7337.
45. Tang, Q., K.J. Henriksen, M. Bi, E.B. Finger, G. Szot, J. Ye, E.L. Masteller, H. McDevitt, M. Bonyhadi, and J.A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199:1455–1465.
46. Battaglia, M., A. Stabilini, E. Draghici, B. Migliavacca, S. Gregori, E. Bonifacio, and M.G. Roncarolo. 2006. Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 55:1571–1580.
47. Groux, H., A. O’garra, M. Bigler, M. Rouleau, S. Antonenko, J.E. De Vries, and M.G. Roncarolo. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737–742.
48. Battaglia, M., S. Gregori, R. Bacchetta, and M.G. Roncarolo. 2006. Tr1 cells: from discovery to their clinical application. Semin Immunol 18:120–127.